BIIB Biogen Inc

USD 216.34 4.32 2.037544
Icon

Biogen Inc (BIIB) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 216.34

+4.32 (+2.04)%

USD 31.70B

1.25M

USD 301.75(+39.48%)

USD 315.88 (+46.01%)

Icon

BIIB

Biogen Inc (USD)
COMMON STOCK | NSD
USD 216.34
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 31.70B

USD 315.88 (+46.01%)

USD 216.34

Biogen Inc (BIIB) Stock Forecast

USD 301.75
(+39.48%)

Based on the Biogen Inc stock forecast from 18 analysts, the average analyst target price for Biogen Inc is USD 301.75 over the next 12 months. Biogen Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Biogen Inc is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Biogen Inc’s stock price was USD 216.34. Biogen Inc’s stock price has changed by -0.83% over the past week, -3.39% over the past month and -19.95% over the last year.

No recent analyst target price found for Biogen Inc
No recent average analyst rating found for Biogen Inc

Company Overview Biogen Inc

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for mu...Read More

https://www.biogen.com

225 Binney Street, Cambridge, MA, United States, 02142

7,570

December

USD

USA

Adjusted Closing Price for Biogen Inc (BIIB)

Loading...

Unadjusted Closing Price for Biogen Inc (BIIB)

Loading...

Share Trading Volume for Biogen Inc Shares

Loading...

Compare Performance of Biogen Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIIB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Biogen Inc (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AZN
AstraZeneca PLC ADR +1.93 (+2.91%) USD210.91B 35.80 16.93

ETFs Containing BIIB

Symbol Name BIIB's Weight Expense Ratio Price(Change) Market Cap
BIS
ProShares UltraShort Nasd.. 6.12 % 0.95 % -0.50 (-2.79%) USD3.90M

Frequently Asked Questions About Biogen Inc (BIIB) Stock

Based on ratings from 18 analysts Biogen Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 20 buy, sell and 6 hold ratings.

Unfortunately we do not have enough data on BIIB's stock to indicate if its a good dividend stock.

Based on targets from 18 analysts, the average taret price for BIIB is USD 301.75 over the next 12 months. The maximum analyst target price is USD 373 while the minimum anlayst target price is USD 239.

BIIB stock's Price/Earning ratio is 27.40. Our analysis grades BIIB stock's Price / Earning ratio at F. This means that BIIB stock's Price/Earning ratio is above 43.00000000000001% of the stocks in the Drug Manufacturers - General sector in the NSD exchange. Based on this BIIB may be fairly valued for its sector

The last closing price of BIIB's stock was USD 216.34.

The most recent market capitalization for BIIB is USD 31.70B.

Based on targets from 18 analysts, the average taret price for BIIB is projected at USD 301.75 over the next 12 months. This means that BIIB's stock price may go up by +39.48% over the next 12 months.

Following are ETFs with the highest allocation to Biogen Inc's stock :

BIS

As per our most recent records Biogen Inc has 7,570 Employees.

Biogen Inc's registered address is 225 Binney Street, Cambridge, MA, United States, 02142. You can get more information about it from Biogen Inc's website at https://www.biogen.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...